The EQUAL Scorecards are an excellent tool to measure current medical guidelines for the treatment of invasive fungal infections. Visit to see all EQUAL Scorecards available in up to 25 languages.


Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials. Thompson III GR, Soriano A, Honore PM, Bassetti M, Cornely OA, Kollef M, Kullberg BJ, Pullman J, Hites M, Fortún J, Horcajada JP, Kotanidou A, Das AF, Sandison T, Aram JA, Vazquez JA, Pappas PG. The Lancet. 2023 Nov 23. doi: 10.1016/S1473-3099(23)00551-0

Questioning the 14-day dogma in candidemia treatment duration.
Salmanton-García J, Reinhold I, Prattes J, Bekaan N, Koehler P, Cornely OA.
Mycoses. 2023 Oct 27. doi: 10.1111/myc.13672. Online ahead of print.

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC.
de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai F-Y, Balada-Llasat J-M,  Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux J-P, Gibas C, Glasgow H, Gräser Y, Guillot J, Groll AH, Haase G, Hanson K, Harrington A,  Hawksworth DL, Hayden RT, Hoenigl M, Hubka V, Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal Jr. SM, Lee F, Lockhart SR, Luethy P, Martin I, Kwon-Chung KJ, Meyer W,  Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, Procop GW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L, Vicente VA, Vitale RG, Wang Q-M, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX.
J Clin Microbiol. 2023 Oct 26:e0087323. doi: 10.1128/jcm.00873-23. Online ahead of print

Invasive Mykosen in Onkologie und Hämatologie: Überlebenschance häufig nur bei sofortigem Handeln.
Stemler J, Bekaan N, Nacov J, Cornely OA.
Dtsch Arztebl 2023; 120(42): [16]; DOI: 10.3238/PersOnko.2023.10.20.03

Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients.
Koehler P, Prattes J, Simon M, Haensel L, Hellmich M, Cornely OA.
Clin Microbiol Infect. 2023 Oct;29(10):1225-1228. doi: 10.1016/j.cmi.2023.05.004. Epub 2023 May 11.

Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.
Cornely OA, Ostermann H, Koehler P, Teschner D, Limburg E, Kramer WG, Barbat SH, Tawadrous M, Hodges MR.
J Antimicrob Chemother. 2023 Sep 8;dkad269. doi: 10.1093/jac/dkad269. Online ahead of print.

Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
Vena A, Bassetti M, Mezzogori L, Marchesi F, Hoenigl M, Giacobbe DR, Corcione S, Bartoletti M, Stemler J, Pagano L, Cornely OA, Salmanton-Garcia J.

Infection. 2023 Sep 1. doi: 10.1007/s15010-023-02084-x. Online ahead of print.

Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG.
Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, Blennow O, Bruzzone B, Calvet L, Marzani FC, Casabella A, Choudaly S, Dartevel A, De Pascale G, Di Meco G, Fallon M, Galerneau LM, Gallego M, Giacomini M, González Sáez A, Hänsel L, Icardi G, Koehler P, Lagrou K, Lahmer T, White PL, Magnasco L, Marchese A, Marelli C, Marín‑Arriaza M, Martin‑Loeches I, Mekontso‑Dessap A, Mikulska M, Mularoni A, Nordlander A, Poissy J, Russelli G, Signori A, Tascini C, Vaconsin LM, Vargas J, Vena A, Wauters J, Pelosi P, Timsit JF and Bassetti M on behalf of JIR-ICU investigators (collaborators) the Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG).
Crit Care. 2023 Aug 24;27(1):323. doi: 10.1186/s13054-023-04608-1.

European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study.
Arendrup MC, Arikan-Akdagli S, Jørgensen KM, Barac A, Steinmann J, Toscano C, Arsenijevic VA, Sartor A, Lass-Flörl C, Hamprecht A, Matos T, Rogers BRS, Quiles I, Buil J, Özenci V, Krause R, Bassetti M, Loughlin L, Denis B, Grancini A, White PL, Lagrou K, Willinger B, Rautemaa-Richardson R, Hamal P, Ener B, Unalan-Altintop T, Evren E, Hilmioglu-Polat S, Oz Y, Ozyurt OK, Aydin F, Růžička F, Meijer EFJ, Gangneux JP, Lockhart DEA, Khanna N, Logan C, Scharmann U, Desoubeaux G, Roilides E, Talento AF, van Dijk K, Koehler P, Salmanton-García J, Cornely OA, Hoenigl M.
J Infect. 2023 Aug 5;S0163-4453(23)00451-6. doi: 10.1016/j.jinf.2023.08.001. Online ahead of print.

The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
Salmanton-García J, Hoenigl M, Salzer HJF, Lackner M, Prattes J, Dichtl K, Winkler-Zamani M, Krause R, Stemler J, Lass-Flörl C, Cornely OC, Willinger B.
Mycoses. 2023 Aug 17. doi: 10.1111/myc.13650. Online ahead of print.

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study
Egger M, Salmanton-Garcia J, Barac A, Gangneux JP, Guegan H, Arsic-Arsenijevic V, Matos T, Tomazin R, Klimko N, Bassetti M, Hammarström H, Meijer EFJ, Meis JF, Prattes J, Krause R, Sipahi OR, Scharmann U, White PL, Desoubeaux G, García-Rodríguez J, Garcia-Vidal C, Martín-Pérez S, Ruiz M, Tumbarello M, Talento AF, Rogers B, Lagrou K, van Praet J, Arikan-Akdagli S, Arendrup MC, Koehler P, Cornely OA, Hoenigl M, on behalf of the ECMM Candida III Study Group$.
Mycopathologia. 2023 Aug 11. doi: 10.1007/s11046-023-00776-4. Online ahead of print.

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) Stemler J, Mellinghoff SC, Khodamoradi Y, Sprute R, Classen AY, Zapke SE, Hoenigl M, Krause R, Schmidt-Hieber M, Heinz WJ, Klein M, Koehler P, Liss B, Koldehoff M, Buhl C, Penack O, Maschmeyer G, Schalk E, Lass-Flörl C, Karthaus M, Ruhnke M, Cornely OA, Teschner D.
J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143.

How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?
Hänsel L, Schumacher J, Denis B, Hamane S, Cornely OA, Koehler P.
Clin Microbiol Infect. 2023 Aug;29(8):1015-1023. doi: 10.1016/j.cmi.2023.04.015. Epub 2023 Apr 20.

Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasis
Jeck J, Jakobs F, Kurte MS, Cornely OA, Kron F.
JAC Antimicrob Resist. 2023 Jun

The Argentinian landscape of mycological diagnostic capacity and treatment accessibility
Riera F, Caeiro JP, Cornely OA, Salmanton-García J.
Med Mycol. 2023 Jun Published: 13 June 2023

DoctorFungus April 2023 Case of the Month: Survival of bilateral Pulmonary Mucormycosis
Nacov J, Stemler J, Hekmat K, Simon M, Sprute R, Mellinghoff S, Schömig T, Cornely OA.
MSG ERC DoctorFungus on 2023 Case of the Month – Doctor Fungus on

Characterization of Treatment Response Outcomes in Chronic Pulmonary Aspergillosis: CPAnet Definitions Versus the Existing Criteria
Sehgal IS, Arora K, Cornely OA, Salzer HJF, Dhooria S, Prasad KT, Garg M, Rudramurthy SM, Muthu V, Aggarwal AN, Chakrabarti A, Agarwal R.
Mycophatologia. 2023 Jun 8. doi: 10.1007/s11046-023-00751-z. Online ahead of print

The silent flucytosine shortage in Europe – not a distant problem.
Sprute R, Duda S, Liekweg A, Simon M, Cornely OA.
Lancet Reg. Health Eur. 2023;30: 100658.

Antifungal prophylaxis and pre-emptive therapy: When and how?
Sprute R, Nacov JA, Neofytos D, Oliverio M, Prattes J, Reinhold I, Cornely OA, Stemler J.
Mol Aspects Med. 2023 May 17;92:101190. doi: 10.1016/j.mam.2023.101190. Online ahead of print

How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?
Hänsel L, Schumacher J, Denis B, Hamane S, Cornely OA, Koehler P.
Clin Microbiol Infect. 2023 Apr 20;S1198-743X(23)00186-6

Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients
Koehler P, Prattes J, Simon M, Haensel L, Hellmich M, Cornely OA.
Clin Microbiol Infect. 2023 May 11;S1198-743X(23)00208-2. doi: 10.1016/j.cmi.2023.05.004. Online ahead of print

COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases
Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydın S, Özdemir B, Khostelidi SN, Klimko N, Cornely O, Zakhour J, Kanj SS, Seidel D, Hoenigl M, Ergönül Ö.
Clin Microbiol Infect. 2023 Mar 13;29(6):722-731. doi: 10.1016/j.cmi.2023.03.008. Online ahead of print

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
Stemler J, Többen C, Lass-Flörl C, Steinmann J, Ackermann K, Rath P-M, Simon M, Cornely OA, Koehler P.
J. Fungi 2023, 9(4), 500;

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.
Hoenigl M, Salmanton-García J, Egger M, Gangneux J-P, Bicanic T, Arikan-Akdagli S, Alastruey-Izquierdo A, Klimko N, Barac A, Özenci V, Meijer EFJ, Khanna N, Bassetti M, Rautemaa-Richardson R, Lagrou K, Adam K-M, Akalin E H, Akova M, Arsenijevic VA, Aujayeb A, Blennow O, Bretagne S, Danion F, Denis B, de Jonge NA, Desoubeaux G, Drgona L, Erben N, Gori A, Rodríguez JG, Garcia-Vidal C, Giacobbe DR, Goodman AL, Hamal P, Hammarström H, Toscano C, Lanternier F, Lass-Flörl C, Lockhart DEA, Longval T, Loughlin L, Matos T, Mikulska M, Narayanan M, Martín-Pérez S, Prattes J, Rogers B, Rahimli L, Ruiz M, Roilides E, Samarkos M, Scharmann U, Sili U, Sipahi OR, Sivakova A, Steinmann J, Trauth J, Turhan O, Van Praet J, Vena A, White PL, Willinger B, Tortorano AM, Arendrup MC, Koehler P, Cornely OA, on behalf of the ECMM Candida III Study Group.
Lancet Infect Dis. 2023 Feb doi:10.1016/S1473-3099(22)00872-6. Online ahead of print.


EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis.
Sprute R, Van Braeckel E, Flick H, Hoenigl M, Kosmidis C, Agarwal R, Davidsen JR, Laursen CB, Cornely OA, Seidel D.
J Antimicrob Chemother. 2022 Nov 14:dkac378. doi:10.1093/jac/dkac378. Online ahead of print. PMID: 36374549
Click here to see the CPA EQUAL Scorecard available in different languages

Clinical Features and Prognostic Factors of Magnusiomyces (Saprochaete) Infections in Hematology. A Multicenter Study of SEIFEM/FungiScope.
Del Principe MI, Seidel D, Criscuolo M, Dargenio M, Rácil Z, Piedimonte M, Marchesi F, Nadali G, Koehler P, Fracchiolla N, Cattaneo C, Klimko N, Spolzino A, Karapinar DY, Demiraslan H, Duarte RF, Demeter J, Stanzani M, Melillo LMA, Basilico CM, Cesaro S, Paterno G, Califano C, Delia M, Buzzatti E, Busca A, Cornely OA*and Pagano L*, behalf of the FUNGISCOPE (Global Emerging Fungal Infection Registry) and the SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) * Equal senior contribution.
Mycoses. 2022 Sep 5. doi: 10.1111/myc.13524. Online ahead of print

Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry.
Sal E, Stemler J, Salmanton-García J, Falces-Romero I, Kredics L, Meyer E, Würstl B, Lass-Flörl C, Racil Z, Klimko N, Cesaro S, Jyoti Kindo A, Wisplinghoff H, Koehler P, Cornely OA, Seidel D.
J Antimicrob Chemother. 2022 Sep 30;77(10):2850-2858. doi: 10.1093/jac/dkac235

COVID-19-associated fungal infections.
Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, Ibrahim AS and Carvalho A.
Nat Microbiol. 2022 Aug;7(8):1127-1140. doi: 10.1038/s41564-022-01172-2. Epub 2022 Aug 2

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.
Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, Nasir N, Bonifaz A, Araiza J, Klimko N, Serris A, Lagrou K, Meis JF, Cornely OA, Perfect JR, White PL, Chakrabarti A, on behalf of ECMM and ISHAM collaborators.
Lancet Microbe. 2022 Jul;3(7):e543-e552. doi: 10.1016/S2666-5247(21)00237-8. Epub 2022 Jan 25

Aspergillus tracheobronchitis in COVID-19 ARDS patients – a cohort study.
Koehler P, von Stillfried S, Borrega JG, Fuchs F, Salmanton-García J, Pult F, Böll B, Eichenauer DA, Shimabukuro-Vornhagen A, Kurzai O, Boor P, Kochanek M, Cornely OA.
Eur Respir J. 2022 May 5;59(5):2103142. doi: 10.1183/13993003.03142-2021. Print 2022 May. PMID: 35144992

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections.
Sprute R, Bethe U, Chen SCA, Cornely OA.
J Antimicrob Chemother. 2022 May 29;77(6):1779-1784. doi: 10.1093/jac/dkac085
Click here to see the Trichosporon EQUAL Scorecard available in different languages

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients – a multinational observational study by the European Confederation of Medical Mycology.
Prattes J, Wauters J, Giacobbe DR, Salmanton-García J, Maertens J, Bourgeois M, Reynders M, Rutsaert L, Van Regenmortel N, Lormans P, Feys S, Reisinger AC, Cornely OA, Lahmer T, Valerio M, Delhaes L, Jabeen K, Steinmann J, Chamula M, Bassetti M, Hatzl S, Rautemaa-Richardson R, Koehler P, Lagrou K, Hoenigl M, The ECMM-CAPA Study Groupy.
Clin Microbiol Infect. 2022 Apr;28(4):580-587. doi: 10.1016/j.cmi.2021.08.014. Epub 2021 Aug 26

CPAnet: the challenges of gaining evidence-based knowledge in chronic pulmonary aspergillosis. 
Sprute R, Salzer HJF, Seidel D.
Eur Respir J. 2022 Apr 21;59(4):2102879. doi: 10.1183/13993003.02879-2021. Print 2022 Apr

Attributable mortality of candidemia at a German tertiary hospital from 1997 to 2001 before the introduction of echinocandins.
Blankenheim Y, Salmanton-García J, Seifert H, Cornely OA, Koehler P.
Mycoses. 2022 Feb;65(2):211-221. doi: 10.1111/myc.13406. Epub 2021 Dec 8

Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals. 
Seidel D, Simon M, Sprute R, Lubnow M, Evert K, Speer C, Seeßle J, Khatamzas E, Merle U, Behrens C, Blau IW, Enghard P, Haas CS, Steinmann J, Kurzai O, Cornely OA.
Mycoses. 2022 Jan;65(1):103-109. doi: 10.1111/myc.13379. Epub 2021 Nov 16


EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
Stemler J, Lackner M, Chen SCA, Hoenigl M, Cornely OA.
J Antimicrob Chemother. 2021 Dec 24;77(1):253-258. doi: 10.1093/jac/dkab355
Click here to see the Scedosporiosis/Lomentosporiosis EQUAL Scorecard available in different languages

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin. 
Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, Lass‑Flörl C, Prattes J, Spec A, Thompson III GR, Wiederhold N, Jenks JD.
Drugs. 2021 Oct;81(15):1703-1729. doi: 10.1007/s40265-021-01611-0. Epub 2021 Oct 9

State of Medical Mycology at German Academic Medical Centres: A Survey of the German-Speaking Mycological Society (DMYKG) and the Paul-Ehrlich-Society for Chemotherapy (PEG).
Groll AH, Gordon K, Buchheidt D, Willinger B, Heinz WJ, Kurzai O, Rickerts V, Cornely OA, The Medical Mycology at German Academic Medical Centers (MMGAMC) Study Group.
Mycosis. 2021 Oct;64(10):1177-1182. doi: 10.1111/myc.13346. Epub 2021 Jul 7

Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.
Hoenigl M, Salmanton-García J, Walsh TJ, Nucci M, Neoh CF, Jenks JD, Lackner M, Sprute R, Al-Hatmi AMS, Bassetti M, Carlesse F, Freiberger T, Koehler P, Lehrnbecher T, Kumar A, Prattes J, Richardson M, Revankar S, Slavin MA, Stemler J, Spiess B, Taj-Aldeen SJ, Warris A, Woo PCY, Young JH, Albus K, Arenz D, Arsic-Arsenijevic V, Bouchara JP, Chinniah TR, Chowdhary A, de Hoog GS, Dimopoulos G, Duarte RF, Hamal P, Meis JF, Mfinanga S, Queiroz-Telles F, Patterson TF, Rahav G, Rogers TR, Rotstein C, Wahyuningsih R, Seidel D, Cornely OA.
Lancet Infect Dis. 2021 Aug;21(8):e246-e257. doi: 10.1016/S1473-3099(20)30784-2. Epub 2021 Feb 16

Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.
Sprute R, Salmanton-García J, Sal E, Malaj X, Ráčil Z, Ruiz de Alegría Puig C, Falces-Romero I, Barać A, Desoubeaux G, Jyoti Kindo A, Morris A J, Pelletier R, Steinmann J, Thompson G R, Cornely O A, Seidel D, Stemler J.
J Antimicrob Chemother. 2021 May 12;76(6):1593-1603. doi: 10.1093/jac/dkab039

Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosis.
Budin S, Salmanton-García J, Koehler P, Stemler J, Cornely OA, Mellinghoff SC. 
J Antimicrob Chemother. 2021 Mar 12;76(4):1070-1077. doi: 10.1093/jac/dkaa518

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Salmanton-García J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, García-Vidal C, Falces-Romero I, Machado M, De la Villa S, Schroeder M, Hoyo I, Hanses F, Ferreira-Paim K, Roberto Giacobbe D, Meis JF, Gangneux JP, Rodríguez-Guardado A, Antinori S, Sal E, Malaj X, Seidel D, Cornely OA, Koehler P, FungiScope European Confederation of Medical Mycology/The International Society for Human and Animal Mycology Working Group.
Emerg Infect Dis. 2021;27(4):1077-1086. doi:10.3201/eid2704.204895. Epub 2021 Feb 4

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports.
Sprute R, Salmanton-García J, Sal E, Malaj X, Falces-Romero I, Hatvani L, Heinemann M, Klimko N, López-Soria L, Meletiadis J, Shruti M, Steinmann J, Seidel D, Cornely OA, Stemler J.
J Antimicrob Chemother. 2021 Feb 11;76(3):765-774. doi: 10.1093/jac/dkaa481

All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections.
Hoenigl M, Levitz SM, Schuetz AN, Zhang SX, Cornely OA.
mBio. 2021 Feb 23;12(1):e02920-20. doi: 10.1128/mBio.02920-20


Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope Ⓡ-Global Registry for Emerging Fungal Infections.
Salmanton-García J, Koehler P, Kindo A, Falces-Romero I, García-Rodríguez J, Ráčil Z, Chen SC, Klimko N, Desoubeaux G, Thompson GR , III, Benítez-Peñuela MÁ, Rodríguez JY, Sheppard DC, Hoenigl M, Le Govic Y, Badali H, Baddley JW, Chander J, Ingram PR, Pakstis DL, Mellinghoff SC, Atıcı S, Cesaro S, Chakrabarti A, Dupont D, González GM, Hatvani L, Herbrecht R, Klyasova G, Lass-Flörl C, Mareș M, Mullane K, Vinh DC, Wisplinghoff H, Lackner M, Cornely OA, Seidel D, ECMM/ISHAM working group.
J Infect. 2020 Nov;81(5):802-815. doi: 10.1016/j.jinf.2020.08.015. Epub 2020 Aug 13

Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope ® registry and cases from the literature.
Stemler J, Hamed K, Salmanton-García J, Rezaei-Matehkolaei A, Gräfe SK, Sal E, Zarrouk M, Seidel D, Abdelaziz Khedr R, Ben-Ami R, Ben-Chetrit E, Roth Y, Cornely OA.
Mycoses. 2020 Oct;63(10):1060-1068. doi: 10.1111/myc.13123. Epub 2020 Aug 29

European confederation of medical mycology expert consult-An ECMM excellence center initiative.
Koehler P, Denis B, Denning DW, Gangneux JP, Hoenigl M, Kontoyiannis DP, Krause R, Lagrou K, Lass-Flörl C, Maertens J, Mareković I, Meis JF, Molina JM, Pleško S, Prattes J, Rath PM, Rautemaa-Richardson R, Richardson M, Segal E, Seidel D, Spriet I, Steinmann J, Verweij PE, Cornely OA; European Confederation of Medical Mycology (ECMM).
Mycoses. 2020 Jun;63(6):566-572. doi: 10.1111/myc.13076. Epub 2020 Apr 13

Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Aslam S, Taplitz R, Revankar SG, Baddley J, Mehta SR, Reed S, Slavin MA, Hoenigl M.
Clin Microbiol Infect. 2020 Jun;26(6):784.e1-784.e5. doi: 10.1016/j.cmi.2020.01.012. Epub 2020 Jan 20

Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry.
Jenks JD, Seidel D, Cornely OA, Chen S, van Hal S, Kauffman C, Miceli MH, Heinemann M, Christner M, Jover Sáenz A, Burchardt A, Kemmerling B, Herbrecht R, Steinmann J, Shoham S, Gräber S, Pagano L, Deeren D, Slavin MA, Hoenigl M.
Mycoses. 2020 May;63(5):437-442. doi: 10.1111/myc.13067. Epub 2020 Apr 15

Quantifying guideline adherence in mucormycosis management using the EQUAL score.
Koehler P, Mellinghoff SC, Stemler J, Otte F, Berkhoff A, Beste N, Budin S, Cornely FB, Evans JM, Fuchs F, Pesch L, Rebholz AW, Reiner O, Schmitt M, Schuckelt J, Spiertz A, Salmanton-García J, Kron F, Cornely OA.
Mycoses. 2020 Apr;63(4):343-351. doi: 10.1111/myc.13047. Epub 2020 Jan 20

Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature.
Seidel D, Hassler A, Salmanton-García J, Koehler P, Mellinghoff SC, Carlesse F, Cheng MP, Falces-Romero I, Herbrecht R, Jover Sáenz A, Klimko N, Mareş M, Lass-Flörl C, Soler-Palacín P, Wisplinghoff H, Cornely OA, Pana Z, Lehrnbecher T.
Int J Infect Dis. 2020 Mar;92:114-122. doi: 10.1016/j.ijid.2019.12.017. Epub 2019 Dec 19

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope ® registry and from the literature.
Stemler J, Salmanton-García J, Seidel D, Alexander BD, Bertz H, Hoenigl M, Herbrecht R, Meintker L, Meißner A, Mellinghoff SC, Sal E, Zarrouk M, Koehler P, Cornely OA.
Mycoses. 2020 Mar;63(3):265-274. doi: 10.1111/myc.13039. Epub 2019 Dec 10


Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J, Seidel D, Koehler P, Mellinghoff SC, Herbrecht R, Klimko N, Ráčil Z, Falces-Romero I, Ingram P, Benítez-Peñuela MÁ, Rodríguez JY, Desoubeaux G, Barać A, García-Vidal C, Hoenigl M, Mehta SR, Cheng MP, Klyasova G, Heinz WJ, Iqbal N, Krause R, Ostermann H, Penack O, Schalk E, Sheppard DC, Willinger B, Wisplinghoff H, Vehreschild JJ, Cornely OA, Vehreschild MJGT; FungiScope® ECMM/ISHAM Working Group.
J Antimicrob Chemother. 2019 Nov 1;74(11):3315-3327. doi: 10.1093/jac/dkz344

Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
Cornely OA, Hoenigl M, Lass‐Flörl C, Chen SCA, Kontoyiannis DP, Morrissey CO, Thompson III GR, for the Mycoses Study Group Education and Research Consortium (MSG‐ERC) and the European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Sep;62(9):716-729. doi: 10.1111/myc.12960. Epub 2019 Jul 19

Invasive Fungal Infection.
von Lilienfeld-Toal M, Wagener J, Einsele H, Cornely OA, Kurzai O.
Dtsch Arztebl Int. 2019 Apr 19;116(16):271-278.doi: 10.3238/arztebl.2019.0271.

Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
Koehler P, Salmanton-García J, Gräfe SK, Koehler FC, Mellinghoff SC, Seidel D, Steinbach A, Cornely OA.
J Hosp Infect. 2019 Mar;101(3):339-346. doi: 10.1016/j.jhin.2018.11.003. Epub 2018 Nov 10

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®.
Seidel D, Meißner A, Lackner M, Piepenbrock E, Salmanton-García J, Stecher M, Mellinghoff S, Hamprecht A, Durán Graeff L, Köhler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild MJGT, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA; FungiScope Group.
Crit Rev Microbiol. 2019 Feb;45(1):1-21. doi: 10.1080/1040841X.2018.1514366. Epub 2019 Jan 10


FungiScope™ — Global Emerging Fungal Infection Registry.
Seidel D, Durán Graeff L, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard D, Herbrecht R, Chowdhary A, Cornely OA; FungiScope Group.
Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631

Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Durán Graeff L, Seidel D, Vehreschild MJGT, Hamprecht A, Kindo A, Racil Z, Demeter J, De Hoog S, Aurbach U, Ziegler M, Wisplinghoff H, Cornely OA; FungiScope Group.
Mycoses. 2017 Apr;60(4):273-279. doi: 10.1111/myc.12595. Epub 2017 Feb 2

Disseminated Fusariosis in Immunocompromised Children – Analysis of Recent Cases Identified in the Global FungiScope Registry.
Hassler A, Lieb A, Seidel D, Simone Cesaro S, Greil J, Klimko N, Khostelidi S, Solopova G, Ogunc D, Durán Graeff L, Cornely OA, Vehreschild MJGT, Lehrnbecher T. 
Pediatr Infect Dis J. 2017 Feb;36(2):230-231. doi: 10.1097/INF.0000000000001396


Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, Roilides E; Collaborators of and/or FungiScope™ Registries.
BMC Infect Dis. 2016 Nov 10;16(1):667. doi: 10.1186/s12879-016-2005-1

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T, Spiess B, Cornely OA, Vehreschild JJ, Rath PM, Steinmann J, Heinz WJ, Hahn J, Krause SW, Kiehl MG, Eherer G, Liebregts T, Koldehoff M, Klein M, Nolte F, Mueller MC, Merker N, Will S, Mossner M, Popp H, Hofmann WK, Reinwald M, Buchheidt D.
Clin Microbiol Infect. 2016 Oct;22(10):862-868. doi: 10.1016/j.cmi.2016.06.021. Epub 2016 Jul 5.

The VITAL study: case control studies are hypothesis-generating.
Cornely OA, Maher RM, Marty FM, Lee M, Vehreschild JJ, Vehreschild MJ.
Lancet Infect Dis. 2016 Aug;16(8):886-7. doi: 10.1016/S1473-3099(16)30192-X

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JA, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJ; VITAL and FungiScope Mucormycosis Investigators.
Lancet Infect Dis. 2016 Jul;16(7):828-837. doi: 10.1016/S1473-3099(16)00071-2. Epub 2016 Mar 9

Epidemiology of invasive aspergillosis and azole resistance in patients
with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJGT.
Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12


Improvement in the outcome of invasive fusariosis in the last decade.
Nucci M, Marr K, Vehreschild M, de Souza C, Velasco E, Cappelano P, Carlesse F, Queiroz-Telles F, Sheppard D, Kindo A, Cesaro S, Hamerschlak N, Solza C, Heinz W, Schaller M, Atalla A, Arikan-Akdagli S, Bertz H, Castro Jr C, Herbrecht R, Hoenigl M, Härter G, Hermansen NE, Josting A, Pagano L, Salles M, Mossad SB, Ogunc D, Pasqualotto A, Araujo V, Troke P, Lortholary O, Cornely O, Anaissie E.
Clin Microbiol Infect. 2014 Jun;20(6):580-5. doi: 10.1111/1469-0691.12409. Epub 2013 Nov 18


Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematological diseases: a report from the SEIFEM and FUNGISCOPE registries.
Pagano L, Cornely O, Caira M, Cesaro S, Gasbarrino C, Girmenia C, Heinz WJ, Herbrecht R, Lass-Flörl C, Nosari A, Potenza L, Racil Z, Rickerts V, Sheppard DC, Simon A, Ullmann AJ, Valentini CG, Vehreschild JJ, Candoni A, Vehreschild MJ.
Haematologica. 2013 Oct;98(10):e127-30. doi: 10.3324/haematol.2012.083063. Epub 2013 May 28

Right flank pain and high fever in a neutropenic patient with acute lymphoblastic leukaemia.
Christopeit M, Lindner A, Surov A, Weber T, Vehreschild MJ, Bialek R, Schmoll HJ.
Mycoses. 2013 Jan;56(1):90-2. doi: 10.1111/j.1439-0507.2012.02231.x. Epub 2012 Aug 13


Making moulds meet. Information retrieval as a basis for understanding Pseudallescheria and Scedosporium.
de Hoog GS, Robert V, Lackner M, Vehreschild MJ, Vehreschild JJ, Symoens F, Göttlich-Fligg E, Garcia-Hermoso D, Harun A, Meyer W, Chen SC, Hamprecht A, Fischer G, Buzina W, Cornely OA, Guarro J, Cano J, Horré R.
Mycoses. 2011 Oct;54 Suppl 3:1-4. doi: 10.1111/j.1439-0507.2011.02122.x


Forty-one Recent Cases of Invasive Zygomycosis from a Global Clinical Registry.
Rüping MJGT, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA.
J Antimicrob Chemother. 2010 Feb;65(2):296-302. doi: 10.1093/jac/dkp430. Epub 2009 Dec 11


Posaconazole concentrations in the central nervous system.
Rüping MJGT, Albermann N, Ebinger F, Burckhard I, Beisel C, Müller C, Vehreschild JJ, Kochanek M, Fätkenheuer G, Bangard C, Ullmann AJ, Herr W, Kolbe K, Hallek M, Cornely OA.
J Antimicrob Chemother. 2008 Dec;62(6):1468-70. doi: 10.1093/jac/dkn409. Epub 2008 Sep 28


2022, Sep

ISHAM 2022, New Delhi, India (Presentation: Global guideline in management, Lomentosporiosis, Azole-resistance in

Aspergillus fumigatus, Rasamsonia and Paecilomyces/Purpureocillium)

2021, Oct

TIMM, Virtual conference, Aberdeen, United Kingdom (Presentation, Abstracts: CPAepi, Trichoderma, Saprochaete spp.)

2021, Jul

ECCMID 2021, Virtual conference (Abstract Trichoderma)

2021, Jun

KIT2021, Virtual conference, Mannheim, Germany (Abstracts: Gastrointestinal mucormycosis and Trichoderma analyses from FungiScope)

2019, Nov

ISHAM, Salvador, Brazil (Abstracts Rasamsonia spp., FungiScope Aspergillus)

2019, Jun 20

24ASM Microbe, San Francisco, USA (Poster MoveOn)

2019, May 24

XXIII SEIMC National Congress, Madrid, Spain (Abstract: FungiScope)

2019, Apr 13

1629th ECCMID, Amsterdam, Netherlands (ESCMID Networking Corner FungiScope, Poster MoveOn)

Authorship Policy

We publish together. Authorship is restricted to those centers contributing cases or translational work or specimens to the subset published. For each contributing center there will be authorship positions available.